Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
A genomic case study of mixed fibrolamellar hepatocellular carcinoma
O. L. Griffith
,
M.Griffith
,
K.Krysiak
, V.Magrini
, A.Ramu
, Z.L.Skidmore
, J.Kunisaki
, R.Austin
, S.McGrath
,
J.Zhang
, R.Demeter
,
T.Graves
, J.M.Eldred
, J.Walker
, D.E.Larson
,
C.A.Maher
,
Y.Lin
,
W.Chapman
, A.Mahadevan
, R.Miksad
I.Nasser, D.W.Hanto, E.R.Mardis
Show 3 others
Show less
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
McDonnell Genome Institute (MGI)
Siteman Cancer Center
Division of Laboratory and Genomic Medicine
Department of Surgery
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Division of Cancer Biology
Section of Transplant Surgery
Division of General Surgery
Section of Stem Cell Biology
DBBS - Molecular Cell Biology
DBBS - Human and Statistical Genetics
DBBS - Biomedical Informatics and Data Science
DBBS - Cancer Biology
DBBS - Computational and Systems Biology
DBBS - Molecular Genetics and Genomics
Brain Tumor Center
DBBS - Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A genomic case study of mixed fibrolamellar hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fibrolamellar Hepatocellular Carcinoma
100%
FL-HCC
75%
DNAJB1-PRKACA
50%
High-level Expression
25%
Liver Samples
25%
Nontumor
25%
Diagnostic Tool
12%
ErbB2
12%
Exome Sequencing
12%
Copy number Variation
12%
Expression Level
12%
Fibrolamellar
12%
Genomic Characterization
12%
Transcriptome Sequencing
12%
Worse Prognosis
12%
Genome Analysis
12%
Mutation Rate
12%
Fusion Transcript
12%
Genomic Mechanisms
12%
NanoString
12%
Malignant Liver Tumor
12%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
PRKACA
80%
Fusion Transcript
60%
RNA Sequencing
20%
Exome Sequencing
20%
Mutation Rate
20%
Medicine and Dentistry
Fibrolamellar Hepatocellular Carcinoma
100%
Liver Tumor
37%
RNA Sequencing
12%
Exome Sequencing
12%
Mutation Rate
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrolamellar Hepatocellular Carcinoma
100%
Liver Tumor
37%
Transcriptome
12%